Kounis syndrome following COVID-19 vaccination.
Chadi AllamNicholas George KounisRoy ChlawitMarc SaoumaGeorges BadaouiPublished in: Proceedings (Baylor University. Medical Center) (2022)
Coronary stent thrombosis is a life-threatening condition induced by multiple factors, including allergic reactions. A 64-year-old man presented with stent thrombosis in the left anterior descending artery and multiple cardiorespiratory arrests immediately after the first dose of the BNT162b1 mRNA vaccine. He underwent emergent percutaneous coronary intervention. Anaphylaxis-induced stent thrombosis, or type III Kounis syndrome, is a highly possible diagnosis. Cardiogenic shock can hide the skin manifestations of anaphylaxis, making this syndrome challenging to diagnose. This clinical case underscores the importance of surveillance for at least 30 minutes after vaccine administration, especially in patients at risk.
Keyphrases
- pulmonary embolism
- percutaneous coronary intervention
- type iii
- coronary artery disease
- case report
- end stage renal disease
- ejection fraction
- sars cov
- newly diagnosed
- coronary artery
- acute coronary syndrome
- acute myocardial infarction
- public health
- prognostic factors
- high glucose
- endothelial cells
- high intensity
- coronary artery bypass grafting
- drug induced
- heart failure
- diabetic rats
- cardiac arrest
- antiplatelet therapy
- respiratory syndrome coronavirus
- aortic stenosis
- wound healing
- patient reported
- coronary artery bypass